Signal Transduction Laboratory (STL)
Barbara Drew, Ph.D.
Dr. Barbara Drew is a postdoctoral fellow and former Masters student in pharmacology who is currently working on the role of ceramide analogs in ovarian, breast, prostate, and pancreatic cancer model systems. She begins her residency in OBGyn in July 2011.
Publications
- Drew BA, Ponnapakkam AP, Wang TL, Liu J, Foroozesh M, Beckman BS. A novel family of ceramide analogs blocks survivan in metastatic ovarian cancer in vitro. Tulane University Health Sciences Center Research Days. Tulane University School of Medicine. New Orleans, LA, Apr 2011.
- Drew BA, Burow ME, Beckman BS. MEK5/ERK5 Pathway: The first fifteen years. Biochim Biophy Acta-Reviews in Cancer, in press, 2011